Answers are grounded in this paper and cite their sources.
The benefits of hormone replacement therapy in alleviating climacteric symptoms, preventing osteoporosis and reducing the incidence of cardiovascular disease and stroke are now generally agreed. Nonetheless, perhaps only 5% of postmenopausal women currently receive adequate treatment often because of patient or clinician fears that such treatment may be associated with harmful side effects.
No takes yet. Share an insight, caveat, or question.
Baber et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: